I have to say: upadacitinib looks very decent for GCA. Not a panacea, but it definitely does something & good safety
Tweet Content
I have to say: upadacitinib looks very decent for GCA. Not a panacea, but it definitely does something & good safety during trial.
Would love to eventually see:
- H2H comparative effect vs toci, secukinumab
- structural outcomes
- long-term safety
#EULAR2024 PBA0001 @RheumNow https://t.co/pHZgCKsoA9 https://t.co/5BxCkkLPti
Links
Show on Archive Page
On
Display in Search Results
On
PDQ
Off